Table 3 Neonatal outcome according to gestational diabetes status.

		No gestational diabetes (n=1647)	Impaired gestational fasting glycaemia (n=723)	Impaired gestational glucose tolerance (n=68)	p-value*
Neonate
	Alive at birth	1624 (98.6%)	719 (99.4%)	61 (89.7%)†‡	<0.001
	Antenatal death	23 (1.3%)	4 (0.6%)	4 (5.9%)†‡	<0.001
	Postnatal death	45 (2.7%)	13 (1.8%)	11 (16.2%)†‡	<0.001
	Discharged alive	1599 (97.1%)	710 (98.2%)	57 (83.8%)†‡	<0.001
	Birth weight	3229±607	3246±587	2899±1003§||	<0.05
	>4000 g	135 (8.2%)	65 (9.0%)	6 (8.8%)	ns
	<1500 g	40 (2.4%)	15 (2.1%)	12 (17.6%)†‡	<0.001
	APGAR 1 min	7.21±0.91	7.28±0.91†	6.68±1.30†‡	<0.001
	<7	111 (6.7%)	49 (6.8%)	11 (16.2%)	ns
	APGAR 5 min	7.91±0.76	7.86±0.71	7.68±1.30	ns
	<7	150 (9.1%)	73 (10.1%)	11 (16.2%)||	ns
	APGAR 10 min	8.65±0.94	8.47±0.86†	8.65±1.49§‡	<0.001
	<7	36 (2.2%)	14 (1.9%)	4 (5.9%)	ns
	30 min glucose (mmol/L)	3.38±0.76	3.41±0.64	2.97±1.24	ns
	<2.0 mmol/L	60 (3.6%)	14 (1.9%)†	9 (13.8%)†‡	<0.001
	IV treatment for children with glucose<2.0 mmol/L	6 (10%)	2 (14%)	2 (22%)||	<0.05
	Deceased children with glucose<2.0 mmol/L	2 (3.3%)	1 (7.1%)	1 (11%)||	ns

^* refers to significant differences between groups; † p<0.01 compared to no gestational diabetes; ‡ p<0.01 compared to impaired gestational fasting glycemia; § p<0.05 compared to no gestational diabetes; || p<0.05 compared to impaired gestational fasting glycemia.